de Northern Trust Eli Lilly LLY Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 10.6 mil M | Vender |
8,796,866
-30,698
| -0.3% | -USD 31.4 M | 1.23% | 11 |
|
|
2026
Q1 | USD 8119 M | Vender |
8,827,564
-7,943
| -0.1% | -USD 8.05 M | 1.07% | 12 |
|
|
2025
Q4 | USD 9495 M | Vender |
8,835,507
-63,528
| -0.7% | -USD 60.7 M | 1.21% | 11 |
|
|
2025
Q3 | USD 6790 M | Vender |
8,899,035
-110,235
| -1% | -USD 82 M | 0.87% | 13 |
|
|
2025
Q2 | USD 7023 M | Vender |
9,009,270
-164,208
| -2% | -USD 128 M | 0.97% | 13 |
|
|
2025
Q1 | USD 7576 M | Vender |
9,173,478
-274,741
| -3% | -USD 229 M | 1.12% | 12 |
|
|
2024
Q4 | USD 7294 M | Comprar |
9,448,219
+1,204,337
| +15% | +USD 997 M | 1.03% | 13 |
|
|
2024
Q3 | USD 7304 M | Vender |
8,243,882
-467,635
| -5% | -USD 420 M | 1.2% | 10 |
|
|
2024
Q2 | USD 7887 M | Vender |
8,711,517
-123,936
| -1% | -USD 99.1 M | 1.33% | 8 |
|
|
2024
Q1 | USD 6874 M | Vender |
8,835,453
-296,890
| -3% | -USD 211 M | 1.19% | 9 |
|
|
2023
Q4 | USD 5323 M | Vender |
9,132,343
-1,025,932
| -10% | -USD 599 M | 0.96% | 13 |
|
|
2023
Q3 | USD 5456 M | Comprar |
10,158,275
+355,317
| +4% | +USD 183 M | 1.06% | 11 |
|
|
2023
Q2 | USD 4597 M | Vender |
9,802,958
-687,502
| -7% | -USD 288 M | 0.88% | 15 |
|
|
2023
Q1 | USD 3603 M | Vender |
10,490,460
-90,928
| -0.9% | -USD 30.7 M | 0.71% | 20 |
|
|
2022
Q4 | USD 3871 M | Vender |
10,581,388
-127,805
| -1% | -USD 45.3 M | 0.81% | 17 |
|
|
2022
Q3 | USD 3463 M | Vender |
10,709,193
-176,383
| -2% | -USD 55.9 M | 0.79% | 16 |
|
|
2022
Q2 | USD 3529 M | Vender |
10,885,576
-382,159
| -3% | -USD 115 M | 0.76% | 20 |
|
|
2022
Q1 | USD 3227 M | Vender |
11,267,735
-179,919
| -2% | -USD 46.3 M | 0.57% | 24 |
|
|
2021
Q4 | USD 3162 M | Vender |
11,447,654
-38,076
| -0.3% | -USD 9.7 M | 0.52% | 28 |
|
|
2021
Q3 | USD 2654 M | Comprar |
11,485,730
+1,207,184
| +12% | +USD 298 M | 0.47% | 35 |
|
|
2021
Q2 | USD 2359 M | Vender |
10,278,546
-72,459
| -0.7% | -USD 14.6 M | 0.42% | 40 |
|
|
2021
Q1 | USD 1934 M | Vender |
10,351,005
-420,134
| -4% | -USD 82.2 M | 0.36% | 51 |
|
|
2020
Q4 | USD 1819 M | Vender |
10,771,139
-231,509
| -2% | -USD 34.6 M | 0.35% | 55 |
|
|
2020
Q3 | USD 1629 M | Vender |
11,002,648
-145,794
| -1% | -USD 22.6 M | 0.36% | 57 |
|
|
2020
Q2 | USD 1830 M | Comprar |
11,148,442
+226,212
| +2% | +USD 34.7 M | 0.43% | 45 |
|
|
2020
Q1 | USD 1515 M | Vender |
10,922,230
-7,718
| -0.1% | -USD 1.06 M | 0.44% | 46 |
|
|
2019
Q4 | USD 1437 M | Vender |
10,929,948
-110,635
| -1% | -USD 12.8 M | 0.32% | 61 |
|
|
2019
Q3 | USD 1235 M | Vender |
11,040,583
-15,515
| -0.1% | -USD 1.73 M | 0.3% | 61 |
|
|
2019
Q2 | USD 1225 M | Comprar |
11,056,098
+32,421
| +0.3% | +USD 3.82 M | 0.29% | 65 |
|
|
2019
Q1 | USD 1430 M | Vender |
11,023,677
-615,145
| -5% | -USD 74.8 M | 0.35% | 57 |
|
|
2018
Q4 | USD 1347 M | Comprar |
11,638,822
+416,787
| +4% | +USD 46.6 M | 0.38% | 49 |
|
|
2018
Q3 | USD 1204 M | Vender |
11,222,035
-8,276
| -0.1% | -USD 827 k | 0.29% | 64 |
|
|
2018
Q2 | USD 958 M | Vender |
11,230,311
-72,186
| -0.6% | -USD 5.93 M | 0.24% | 79 |
|
|
2018
Q1 | USD 874 M | Vender |
11,302,497
-473,444
| -4% | -USD 38.1 M | 0.23% | 87 |
|
|
2017
Q4 | USD 995 M | Vender |
11,775,941
-265,813
| -2% | -USD 22.6 M | 0.25% | 78 |
|
|
2017
Q3 | USD 1030 M | Comprar |
12,041,754
+574,263
| +5% | +USD 47.1 M | 0.27% | 72 |
|
|
2017
Q2 | USD 944 M | Vender |
11,467,491
-128,875
| -1% | -USD 10.5 M | 0.26% | 71 |
|
|
2017
Q1 | USD 975 M | Comprar |
11,596,366
+224,978
| +2% | +USD 18 M | 0.28% | 68 |
|
|
2016
Q4 | USD 836 M | Vender |
11,371,388
-179,266
| -2% | -USD 13.4 M | 0.26% | 70 |
|
|
2016
Q3 | USD 927 M | Comprar |
11,550,654
+120,175
| +1% | +USD 9.6 M | 0.29% | 67 |
|
|
2016
Q2 | USD 900 M | Vender |
11,430,479
-15,008
| -0.1% | -USD 1.13 M | 0.29% | 66 |
|
|
2016
Q1 | USD 829 M | Vender |
11,445,487
-60,586
| -0.5% | -USD 4.58 M | 0.27% | 69 |
|
|
2015
Q4 | USD 970 M | Vender |
11,506,073
-678,310
| -6% | -USD 56.3 M | 0.32% | 62 |
|
|
2015
Q3 | USD 1020 M | Vender |
12,184,383
-70,566
| -0.6% | -USD 5.96 M | 0.34% | 55 |
|
|
2015
Q2 | USD 1023 M | Comprar |
12,254,949
+586
| +0% | +USD 44.7 k | 0.31% | 68 |
|
|
2015
Q1 | USD 890 M | Vender |
12,254,363
-233,320
| -2% | -USD 16.6 M | 0.27% | 75 |
|
|
2014
Q4 | USD 862 M | Vender |
12,487,683
-290,019
| -2% | -USD 19.6 M | 0.26% | 82 |
|
|
2014
Q3 | USD 829 M | Vender |
12,777,702
-443,081
| -3% | -USD 28.1 M | 0.26% | 80 |
|
|
2014
Q2 | USD 822 M | Comprar |
13,220,783
+252,915
| +2% | +USD 15.1 M | 0.26% | 83 |
|
|
2014
Q1 | USD 763 M | Vender |
12,967,868
-549,980
| -4% | -USD 30.7 M | 0.24% | 87 |
|
|
2013
Q4 | USD 689 M | Comprar |
13,517,848
+159,989
| +1% | +USD 8.01 M | 0.22% | 91 |
|
|
2013
Q3 | USD 672 M | Vender |
13,357,859
-510,841
| -4% | -USD 26.7 M | 0.24% | 87 |
|
|
2013
Q2 | USD 681 M | Comprar |
+13,868,700
| Nuevas | +USD 755 M | 0.25% | 84 |
|
Otros fondos que tienen LLY en su cartera
Posición de Northern Trust en LLY: resumen de T2 2026
Northern Trust redujo su participación en Eli Lilly (LLY) en 0.35% durante T2 2026, al vender acciones por un valor estimado de USD 31.4 M, y conservó 8,796,866 acciones valuadas en USD 10.6 mil M. La posición representa 1.23% de la cartera y ocupa el puesto #11.
Northern Trust reportó por primera vez una posición en LLY en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 4,654 fondos que sigue Wall St. Rank mantienen una posición en LLY.
- Al cierre de T2 2026, Northern Trust tenía 8,796,866 acciones de Eli Lilly con un valor de USD 10.6 mil M.
- Northern Trust vendió 30,698 acciones de Eli Lilly en T2 2026, por un valor estimado de USD 31.4 M.
- Eli Lilly representó 1.23% de la cartera de Northern Trust en T2 2026 y fue su posición número 11.
- Northern Trust reportó por primera vez una posición en Eli Lilly en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 4,654 fondos que sigue Wall St. Rank tenían Eli Lilly en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.